The blood brain barrier (BBB) is a complex structure that separates brain interstitial fluid from blood. BBB dysfunction is a key feature of Central Nervous System diseases. This in vivo study examines the effects of Intravenous Immunoglobulin (IVIg), regularly used to treat immune and inflammatory diseases, on BBB function following LPS-induced BBB disruption. The change in permeability of the BBB was evaluated by MRI, using gadolinium. Our results suggest that LPS breach the integrity of the BBB with regional specificity and can be reversed by IVIg administration.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords